These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12621166)

  • 21. [The paraoxonase Gln-Arg 192 polymorphism in patients with endogenous hypertriglyceridemia in Chinese population].
    Liu R; Bai H; Liu Y; Huang M; Fan P; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Apr; 33(2):229-32. PubMed ID: 12575193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human paraoxonase 1 gene polymorphisms and the risk of coronary heart disease: a community-based study.
    Watzinger N; Schmidt H; Schumacher M; Schmidt R; Eber B; Fruhwald FM; Zweiker R; Kostner GM; Klein W
    Cardiology; 2002; 98(3):116-22. PubMed ID: 12417809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
    Yamada A; Shoji T; Tahara H; Emoto M; Nishizawa Y
    Metabolism; 2001 Jul; 50(7):805-11. PubMed ID: 11436186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraoxonase (PON1) polymorphism & its relation with lipids in north west Indian Punjabis.
    Singh S; Verma M; Nain CK; Leelamma CO; Goel RC
    Indian J Med Res; 1999 Oct; 110():133-7. PubMed ID: 10645101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of association between Alzheimer's disease and Gln-Arg 192 Q/R polymorphism of the PON-1 gene in an Italian population.
    Pola R; Gaetani E; Flex A; Gerardino L; Aloi F; Flore R; Serricchio M; Pola P; Bernabei R
    Dement Geriatr Cogn Disord; 2003; 15(2):88-91. PubMed ID: 12566597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraoxonase 1 Activity Is Modulated by the rs662 Polymorphism and IgG Anti-High-Density Lipoprotein Antibodies in Patients With Rheumatoid Arthritis: Potential Implications for Cardiovascular Disease.
    Rodríguez-Carrio J; López-Mejías R; Alperi-López M; López P; Ballina-García FJ; González-Gay MÁ; Suárez A
    Arthritis Rheumatol; 2016 Jun; 68(6):1367-76. PubMed ID: 26815637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
    Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
    Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate.
    Hegele RA; Brunt JH; Connelly PW
    Arterioscler Thromb Vasc Biol; 1995 Jan; 15(1):89-95. PubMed ID: 7749820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraoxonase gene polymorphisms and coronary reactivity in young healthy men.
    Malin R; Knuuti J; Janatuinen T; Laaksonen R; Vesalainen R; Nuutila P; Jokela H; Laakso J; Jaakkola O; Solakivi T; Lehtimäki T
    J Mol Med (Berl); 2001 Aug; 79(8):449-58. PubMed ID: 11511975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PON1 polymorphisms are predictors of ability to attain HDL-C goals in statin-treated patients.
    de Souza JA; Menin A; Lima LO; Smiderle L; Hutz MH; Van Der Sand CR; Van Der Sand LC; Ferreira ME; Pires RC; Almeida S; Fiegenbaum M
    Clin Biochem; 2015 Nov; 48(16-17):1039-44. PubMed ID: 26079344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LL-paraoxonase genotype is associated with a more severe degree of homeostasis model assessment IR in healthy subjects.
    Barbieri M; Bonafè M; Marfella R; Ragno E; Giugliano D; Franceschi C; Paolisso G
    J Clin Endocrinol Metab; 2002 Jan; 87(1):222-5. PubMed ID: 11788650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumers.
    Sierksma A; van der Gaag MS; van Tol A; James RW; Hendriks HF
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1430-5. PubMed ID: 12351939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum lipid levels and M/L55 allele distribution of HDL paraoxonase gene in Saami and Finnish men.
    Malin R; Lehtinen S; Luoma P; Näyhä S; Hassi J; Koivula T; Lehtimäki T
    Int J Circumpolar Health; 2001 Jan; 60(1):16-24. PubMed ID: 11428219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women.
    Rantala M; Silaste ML; Tuominen A; Kaikkonen J; Salonen JT; Alfthan G; Aro A; Kesäniemi YA
    J Nutr; 2002 Oct; 132(10):3012-7. PubMed ID: 12368388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multiplex PCR-based DNA assay for the detection of paraoxonase gene cluster polymorphisms.
    Motti C; Dessì M; Gnasso A; Irace C; Indigeno P; Angelucci CB; Bernardini S; Fucci G; Federici G; Cortese C
    Atherosclerosis; 2001 Sep; 158(1):35-40. PubMed ID: 11500172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A preliminary study of human paraoxonase and PON 1 L/M55-PON 1 Q/R 192 polymorphisms in Turkish patients with coronary artery disease.
    Kaman D; Ilhan N; Metin K; Akbulut M; Ustündağ B
    Cell Biochem Funct; 2009 Mar; 27(2):88-92. PubMed ID: 19226538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study.
    Herrmann SM; Blanc H; Poirier O; Arveiler D; Luc G; Evans A; Marques-Vidal P; Bard JM; Cambien F
    Atherosclerosis; 1996 Oct; 126(2):299-303. PubMed ID: 8902155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
    Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of statin therapy on plasma high-density lipoprotein-cholesterol levels is modified by paraoxonase 1 in Chinese patients with coronary heart disease.
    Fu R; Sun YM; Su Y; Wu Y; Luan Y
    Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):982-3. PubMed ID: 18430057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.